Published in J Biol Regul Homeost Agents on July 27, 1989
Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest (2005) 2.06
The first US domestic report of disseminated Mycobacterium avium complex and anti-interferon-γ autoantibodies. J Clin Immunol (2014) 0.86
Natural human antibodies to gamma interferon interfere with the immunomodulating activity of the lymphokine. Proc Natl Acad Sci U S A (1992) 0.86
Autoantibody to interferon-gamma associated with adult-onset immunodeficiency in non-HIV individuals in Northern Thailand. PLoS One (2013) 0.85
Potential role of autoantibodies in the regulation of cytokine responses during bacterial infections. Infect Immun (1997) 0.80
Induction of cytokines and anti-cytokine autoantibodies in cerebrospinal fluid (CSF) during experimental bacterial meningitis. Clin Exp Immunol (1998) 0.78
Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis. J Thromb Haemost (2014) 2.15
Monoclonal antibodies against murine gamma interferon. Proc Natl Acad Sci U S A (1984) 1.95
Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. Cytometry (1997) 1.80
Morphological transformation of mouse embryo cells in vitro by murine sarcoma virus (Harvey). Nature (1967) 1.67
The Ifi 200 genes: an emerging family of IFN-inducible genes. Biochimie (1999) 1.61
Inhibition of interferon-gamma may suppress allograft reactivity by T lymphocytes in vitro and in vivo. Science (1985) 1.30
Monoclonal antibodies to interferon-gamma inhibit interleukin 2-dependent induction of growth and maturation in lectin/antigen-reactive cytolytic T lymphocyte precursors. J Immunol (1986) 1.27
Natural cell-mediated cytotoxicity against Trichomonas vaginalis in the mouse. I. Tissue, strain, age distribution, and some characteristics of the effector cells. J Immunol (1980) 1.18
Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity. J Immunol (1988) 1.15
Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment. J Infect Dis (2000) 1.14
Redistribution of the nuclear protein IFI16 into the cytoplasm of ultraviolet B-exposed keratinocytes as a mechanism of autoantigen processing. Br J Dermatol (2011) 1.13
Natural antibodies to IFN-gamma in man and their increase during viral infection. J Immunol (1990) 1.10
Inhibition of HIV type 1 BaL replication by MIP-1alpha, MIP-1beta, and RANTES in macrophages. AIDS Res Hum Retroviruses (1998) 1.10
Productive HIV-1 infection of normal human mammary epithelial cells. AIDS (1995) 1.09
Differences in the expression and release of DR, BR, and DQ molecules in human cells treated with recombinant interferon gamma: comparison to other interferons. Hum Immunol (1985) 1.09
Interferon action: binding of viral RNA to the 40-kilodalton 2'-5'-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus. J Virol (1991) 1.08
Rufloxacin (MF-934): in vitro and in vivo antibacterial activity. Drugs Exp Clin Res (1989) 1.07
Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta. Infect Immun (1983) 1.06
Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication. J Virol (2000) 1.05
Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis. Mult Scler (2010) 1.03
Production of immune interferon is regulated by more than T cell subset: Lyt-1,2,3 and Qat-5 phenotypes of murine T lymphocytes involved in IFN-gamma production in primary and secondary mixed lymphocyte reaction. Eur J Immunol (1982) 1.02
Role of reactive oxygen intermediates in the interferon-mediated depression of hepatic drug metabolism and protective effect of N-acetylcysteine in mice. Cancer Res (1985) 1.02
Multiple sclerosis-associated retrovirus in early multiple sclerosis: a six-year follow-up of a Sardinian cohort. Mult Scler (2006) 1.01
Murine cytomegalovirus replication in salivary glands is controlled by both perforin and granzymes during acute infection. Eur J Immunol (2000) 1.01
Monoclonal antibody against IFN-gamma inhibits Moloney murine sarcoma virus-specific cytotoxic T lymphocyte differentiation. J Immunol (1988) 1.01
CD11b expression identifies CD8+CD28+ T lymphocytes with phenotype and function of both naive/memory and effector cells. J Immunol (2001) 1.01
Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription. Virology (1993) 1.00
Increased frequency of detection of Ureaplasma urealyticum and Mycoplasma genitalium in AIDS patients without urethral symptoms. J Clin Microbiol (1999) 1.00
Mouse soluble IFN gamma receptor as IFN gamma inhibitor. Distribution, antigenicity, and activity after injection in mice. J Immunol (1993) 1.00
Inhibition of transcription and translation of globin messenger RNA in dimethyl sulfoxide-stimulated Friend erythroleukemic cells treated with interferon. Proc Natl Acad Sci U S A (1977) 0.99
Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy. Cell Death Dis (2010) 0.99
Direct and cell-mediated effects of interferon-alpha and -gamma on cells chronically infected with HTLV-III. J Interferon Res (1986) 0.97
Interferons as gene activators. Characteristics of an interferon-activatable enhancer. J Biol Chem (1987) 0.97
Interferon-alpha inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-kappa B activity. Virology (1995) 0.96
Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent fibroblasts. J Virol (2000) 0.96
Productive HIV-1 infection of human vascular endothelial cells requires cell proliferation and is stimulated by combined treatment with interleukin-1 beta plus tumor necrosis factor-alpha. J Med Virol (1995) 0.96
Expression of CD28 on CD8+ and CD4+ lymphocytes during HIV infection. Scand J Immunol (1994) 0.96
Usefulness of genus-specific PCR and Southern blot species-specific hybridization for the detection of imported malaria cases in Italy. New Microbiol (2001) 0.95
Contribution of CD4+, CD8+CD28+, and CD8+CD28- T cells to CD3+ lymphocyte homeostasis during the natural course of HIV-1 infection. J Clin Invest (1998) 0.95
Heparin-binding domain of human fibronectin binds HIV-1 gp120/160 and reduces virus infectivity. J Med Virol (1998) 0.95
Persistent infection of human vascular endothelial cells by group B coxsackieviruses. J Infect Dis (1997) 0.95
In vivo treatment with a monoclonal antibody to interferon-gamma neither affects the survival nor the incidence of lupus-nephritis in the MRL/lpr-lpr mouse. Immunopharmacology (1993) 0.94
CD4+ and CD8+ lymphocytes of patients with AIDS synthesize increased amounts of interferon-gamma. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.94
The HMG protein T160 colocalizes with DNA replication foci and is down-regulated during cell differentiation. Exp Cell Res (1999) 0.94
A comparison of Legionella pneumophila occurrence in hot water tanks and instantaneous devices in domestic, nosocomial, and community environments. Curr Microbiol (2000) 0.94
Interferon-gamma is not an antiviral, but a growth-promoting factor for T lymphocytes. Eur J Immunol (1988) 0.94
Reduced virulence in ciprofloxacin-resistant variants of Pseudomonas aeruginosa strains. J Antimicrob Chemother (1987) 0.93
Enhancing effect of IFN-gamma on helper T cell activity and IL 2 production. J Immunol (1985) 0.93
Characterization of T cell subsets involved in the production of IFN-gamma in asymptomatic HIV-infected patients. AIDS Res Hum Retroviruses (1996) 0.90
Interactions of interferon with in vitro model systems involved in hematopoietic cell differentiation. Ann N Y Acad Sci (1980) 0.90
HIV p17 enhances lymphocyte proliferation and HIV-1 replication after binding to a human serum factor. AIDS (1998) 0.90
Inhibition of cell proliferation by the interferon-inducible 204 gene, a member of the Ifi 200 cluster. Oncogene (1998) 0.89
The murine cytomegalovirus immediate-early 1 protein stimulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 promoter. Virus Res (1996) 0.89
Mechanisms of viral inhibition by interferons. Pharmacol Ther (1995) 0.88
Chronic myeloid leukemia cells resistant to interferon-alpha lack STAT1 expression. Hematol J (2000) 0.88
Evaluation of OptiMAL Assay test to detect imported malaria in Italy. New Microbiol (2000) 0.88
Persistence of human T cell lymphotropic virus type 1 (HTLV-1) sequences in peripheral blood mononuclear cells from patients with mycosis fungoides. J Exp Med (1994) 0.88
Multiple sclerosis-associated retrovirus and MS prognosis: an observational study. Neurology (2002) 0.88
Affinity purification, peptide analysis, and cDNA sequence of the mouse interferon gamma receptor. J Biol Chem (1990) 0.88
Effects of dexamethasone on human natural killer cell cytotoxicity, interferon production, and interleukin-2 receptor expression induced by microbial antigens. Infect Immun (1986) 0.88
Immune (y) interferon production by murine T cell lymphomas. J Immunol (1982) 0.87
HIV-persistent infection and cytokine induction in mesangial cells: a potential mechanism for HIV-associated glomerulosclerosis. AIDS (2000) 0.87
Detection of Mycoplasma genitalium from urethral swabs of human immunodeficiency virus-infected patients. New Microbiol (1996) 0.87
Differential production of IFN-gamma, analyzed at the single-cell level, by specific subsets of human NK and T cells from healthy and HIV(+) subjects. Cytometry (2000) 0.87
Search for malaria parasites by PCR and Southern blot in patients with imported malaria in Italy. New Microbiol (2000) 0.87
Differential effects of gamma interferon on expression of HLA class II molecules controlled by the DR and DC loci. Infect Immun (1983) 0.87
In-vitro activity of cefotetan and other cephalosporins on Klebsiella and resistance to inactivating bacterial enzymes. J Antimicrob Chemother (1983) 0.87
Mouse immune interferon enhances fibronectin production of elicited macrophages. J Immunol (1984) 0.87
Multiple sclerosis-associated retrovirus and optic neuritis. Mult Scler (2006) 0.86
Phenotypic and functional characteristics of tumour-derived microvascular endothelial cells. Clin Exp Metastasis (1999) 0.86
Detection of specific immunoglobulin M antibody to rubella virus by use of an enzyme-labeled antigen. J Clin Microbiol (1985) 0.86
Natural human antibodies to gamma interferon interfere with the immunomodulating activity of the lymphokine. Proc Natl Acad Sci U S A (1992) 0.86
Segregation of type 1 cytokine production in human peripheral blood lymphocytes: phenotypic differences between IFN-gamma and IL-2-producing cells in the CD8+ T cell subset. Eur J Immunol (1998) 0.86
The high-mobility group protein T160 binds to both linear and cruciform DNA and mediates DNA bending as determined by ring closure. Exp Cell Res (1997) 0.86
Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index. Histopathology (2004) 0.85
Impaired transcription of the poly rI:rC- and interferon-activatable 202 gene in mice and cell lines from the C57BL/6 strain. Virology (1992) 0.85
Evaluation of BACTEC system for urine culture screening. J Clin Microbiol (1989) 0.85
Activation of interferon-inducible genes in vivo by synthetic double-stranded RNA, poly rI:rC. Microbiologica (1991) 0.85
The interferon-inducible 204 gene is transcriptionally activated by mouse cytomegalovirus and is required for its replication. Virology (2001) 0.85
Multiple sclerosis and multiple sclerosis-associated retrovirus in Sardinia. Neurol Sci (2001) 0.85
Natural antibodies to interferon-gamma. Biotherapy (1997) 0.84
Liquid competition radioimmunoassay for the detection and quantitation of the HIV p24. J Virol Methods (1987) 0.84
The murine homolog of the HIN 200 family, Ifi 204, is constitutively expressed in myeloid cells and selectively induced in the monocyte/macrophage lineage. J Leukoc Biol (1998) 0.84
Evaluation of the expression of IFN-gamma in lymphocytes using a monoclonal antibody and flow cytometry. J Immunol Methods (1988) 0.84
Murine cytomegalovirus induces expression and enzyme activity of cellular dihydrofolate reductase in quiescent cells. J Gen Virol (1998) 0.84
The retinoblastoma protein is an essential mediator that links the interferon-inducible 204 gene to cell-cycle regulation. Oncogene (2000) 0.84